David Reynolds
Directeur Général chez Loqus23 Therapeutics Ltd.
Postes actifs de David Reynolds
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Private Equity Investor | - | - |
Loqus23 Therapeutics Ltd.
 Loqus23 Therapeutics Ltd. BiotechnologyHealth Technology Loqus23 Therapeutics Ltd.engages in research and development of biotechnology. The company was founded on March 29, 2019 and is headquartered in in Reading, the United Kingdom. | Directeur/Membre du Conseil | 29/03/2019 | - |
| Directeur Général | - | - |
Historique de carrière de David Reynolds
Statistiques
Internationale
| Etats-Unis | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Finance | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |
Loqus23 Therapeutics Ltd.
Loqus23 Therapeutics Ltd. BiotechnologyHealth Technology Loqus23 Therapeutics Ltd.engages in research and development of biotechnology. The company was founded on March 29, 2019 and is headquartered in in Reading, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- David Reynolds
- Expérience
